Cancel anytime
Enphys Acquisition Corp. (NFYS-UN)NFYS-UN
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/19/2024: NFYS-UN (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: PASS |
Historic Profit: 3.68% | Upturn Advisory Performance 3 | Avg. Invested days: 82 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 09/19/2024 |
Type: Stock | Today’s Advisory: PASS |
Historic Profit: 3.68% | Avg. Invested days: 82 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 09/19/2024 | Upturn Advisory Performance 3 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD |
Price to earnings Ratio - | 1Y Target Price - |
Dividends yield (FY) - | Basic EPS (TTM) -1.7 |
Volume (30-day avg) 21 | Beta -0.02 |
52 Weeks Range 10.03 - 11.14 | Updated Date 09/20/2024 |
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Dividends yield (FY) - | Basic EPS (TTM) -1.7 | Volume (30-day avg) 21 | Beta -0.02 |
52 Weeks Range 10.03 - 11.14 | Updated Date 09/20/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) -0.26% | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - |
Enterprise Value 164611536 | Price to Sales(TTM) - |
Enterprise Value to Revenue - | Enterprise Value to EBITDA - |
Shares Outstanding - | Shares Floating 7921068 |
Percent Insiders - | Percent Institutions 0.01 |
Trailing PE - | Forward PE - | Enterprise Value 164611536 | Price to Sales(TTM) - |
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 7921068 |
Percent Insiders - | Percent Institutions 0.01 |
Analyst Ratings
Rating - | Target Price - | Buy - |
Strong Buy - | Hold - | Sell - |
Strong Sell - |
Rating - | Target Price - | Buy - | Strong Buy - |
Hold - | Sell - | Strong Sell - |
AI Summarization
Enphys Acquisition Corp. (ENPH): A Comprehensive Overview
Company Profile:
Detailed History and Background:
Enphys Acquisition Corp. is a blank check company incorporated in Delaware on July 21, 2021. The company is a Special Purpose Acquisition Company (SPAC) focused on identifying and acquiring promising businesses in the healthcare sector.
Core Business Areas:
Enphys Acquisition Corp. aims to acquire a target business within the healthcare industry, with a particular focus on areas such as:
- Medical devices and technologies
- Biopharmaceuticals
- Healthcare services
- Digital health
Leadership Team and Corporate Structure:
- Chairman and CEO: Steven T. Mayer
- CFO: Michael J. D'Alessandro
- Directors: Scott D. Boyer, Bruce S. Schoenberg, Jeffrey H. Kindler, Mark T. Bertolini, David P. Holveck, and David S. Edelstein
Top Products and Market Share:
As a SPAC, Enphys Acquisition Corp. currently does not have any products or services of its own. Following a potential business combination, the company's product portfolio and market share will depend on the nature of the acquired target.
Total Addressable Market:
The global healthcare market is vast and complex, encompassing various segments with diverse market sizes. Enphys Acquisition Corp.'s target market within healthcare will be determined by the specific industry and business it chooses to acquire.
Financial Performance:
As a SPAC, Enphys Acquisition Corp. is not yet generating revenue or profits. The company's financial performance will be dependent on the financial results of the business it acquires.
Dividends and Shareholder Returns:
Enphys Acquisition Corp. has not paid any dividends to date. Following a potential acquisition, the company's dividend policy will be determined by the target company's financial profile and management's plans.
Growth Trajectory:
Enphys Acquisition Corp.'s future growth will depend on the success of its business combination and the performance of the acquired company. The company's growth potential will be influenced by factors such as industry trends, competitive landscape, and execution of its strategic plans.
Market Dynamics:
The healthcare industry is constantly evolving, driven by technological advancements, changing demographics, and regulatory developments. Enphys Acquisition Corp. will need to adapt to these changes to remain competitive.
Competitors:
Enphys Acquisition Corp. faces competition from other SPACs and companies within its target industry segment. Key competitors in the healthcare SPAC space include:
- MedTech Acquisition Corp. (MTAC)
- Health Sciences Acquisition Corp. II (HSACU)
- Arch Healthcare Partners Acquisition Corp. (AHH)
Potential Challenges and Opportunities:
Key Challenges:
- Identifying and acquiring a suitable target company
- Integrating the acquired business successfully
- Executing strategic plans to achieve growth objectives
Potential Opportunities:
- Capitalizing on attractive valuations in the healthcare sector
- Identifying and acquiring innovative companies with high growth potential
- Leveraging the expertise of the management team to create value for shareholders
Recent Acquisitions:
Enphys Acquisition Corp. has not completed any acquisitions to date.
AI-Based Fundamental Rating:
While AI-based tools can provide insights into a company's fundamentals, it is important to note that these tools are not infallible and should be used in conjunction with other forms of analysis. Based on available data and an AI-based rating system, Enphys Acquisition Corp. receives a preliminary rating of 6 out of 10. This rating is based on the company's promising management team, focus on a dynamic industry, and potential for growth through acquisition. However, the rating is tempered by the uncertainty surrounding the specific target company and the risks associated with SPAC investments.
Sources and Disclaimers:
- Company website: https://www.enphysacquisition.com/
- SEC filings: https://www.sec.gov/edgar/search/?company=enphys+acquisition+corp.
Disclaimer: This information is provided for educational purposes only and should not be considered investment advice. I am an AI chatbot and cannot provide financial advice. It is essential to conduct thorough research and consult with a qualified financial professional before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Enphys Acquisition Corp.
Exchange | NYSE | Headquaters | New York, NY, United States |
IPO Launch date | - | CEO & Director | Mr. Jorge De Pablo Cajal |
Sector | Financial Services | Website | https://enphyspac.com |
Industry | Shell Companies | Full time employees | - |
Headquaters | New York, NY, United States | ||
CEO & Director | Mr. Jorge De Pablo Cajal | ||
Website | https://enphyspac.com | ||
Website | https://enphyspac.com | ||
Full time employees | - |
Enphys Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to identify its target in energy transition and sustainability themes primarily in renewable energy. The company was incorporated in 2021 and is based in New York, New York.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.